GLAZE-M1
Glimepiride 1 mg. + Metformin Hydrochloride 500mg.(ER) Tabs
- 65.3째/o patients had reduction in insulin resistance
- Metformin helps to reduce the CV burden in type 2 diabetes
- Superio HbA1c lowering
- Comparable safety and tolerability
Uncontrolled with metformin Offers Control with Convenience
GLAZE-M2
Glimepiride 1 mg. + Metformin Hydrochloride 500mg.(ER) Tabs
- 65.3째/o patients had reduction in insulin resistance
- Metformin helps to reduce the CV burden in type 2 diabetes
- Superio HbA1c lowering
- Comparable safety and tolerability
Uncontrolled with metformin Offers Control with Convenience
GLAZE-MP 1
Glimepiride 1 mg.+ Metformin Hydrochloride 500 mg. + Pioglitazone Hydrochloride 15 mg.(ER) Tabs.
Glimepride
- An antidiabetic with least risk of hypoglycemia.
- Decreases HbA 1 c by 1.2-1.9% in patients with type 2 diabetes mellitus, which is not sufficiently controlled by diet and exercise.
Metformin
- Improves lipid profile of body by reducing
- Provides weight stabilisation or reduction. hypertriglyceridemia.
- Reduces the amount of glucose produced by the liver and preserves the function of the cells in the pancreas.
Pioglitazone
- Highly useful in diabetic patients with CKD (Chronic kidney disease).
- Decreases blood glucose levels up to 95 mg/di and glycosylated haemoglobin up to 2.6%.
- Causes significant improvements in Myocardial glucose utilization and Myocardial blood flow.
Helps keep the CONTROL
GLAZE-MP 2
Glimepiride 1 mg.+ Metformin Hydrochloride 500 mg. + Pioglitazone Hydrochloride 15 mg.(ER) Tabs.
Glimepride
- An antidiabetic with least risk of hypoglycemia.
- Decreases HbA 1 c by 1.2-1.9% in patients with type 2 diabetes mellitus, which is not sufficiently controlled by diet and exercise.
Metformin
- Improves lipid profile of body by reducing
- Provides weight stabilisation or reduction. hypertriglyceridemia.
- Reduces the amount of glucose produced by the liver and preserves the function of the cells in the pancreas.
Pioglitazone
- Highly useful in diabetic patients with CKD (Chronic kidney disease).
- Decreases blood glucose levels up to 95 mg/di and glycosylated haemoglobin up to 2.6%.
- Causes significant improvements in Myocardial glucose utilization and Myocardial blood flow.
Helps keep the CONTROL
GLAZE-VG1 Tabs
Glimepiride 1 mg. +Metformin Hydrochloride 500 mg. & Voglibose 0.2 mg. (SR) Tabs
- Reduces HbA 1c & FPG to the target level
- Reduces VLDL & FFA
- Cost effective
- Negligible chances of missing dose
- Motivates patient compliance
Prescribe For Healthy Brain, Bone, Skin & CV Function, Total Metabolism Protects against - Inflammation, CVD and Hair Problems
GLAZE-VG2 Tabs
Glimepiride 2 mg. +Metformin Hydrochloride 500 mg. & Voglibose 0.2 mg. (SR) Tabs
- Reduces HbA 1c & FPG to the target level
- Reduces VLDL & FFA
- Cost effective
- Negligible chances of missing dose
- Motivates patient compliance
Prescribe For Healthy Brain, Bone, Skin & CV Function, Total Metabolism Protects against - Inflammation, CVD and Hair Problems
TELL – 40 Tabs
Telmisartan 40 mg
- Additive BP reduction and benefits beyond BP lowering1>
- SBP by 30 mmHg1
- New onset of diabetes by 16%1
- HOMA-IR by 15%2
- First choice in hypertension with carotid artery atherosclerosis3
- Decreases IMT by 7%
- Decreases IMT by 7%
- Reverses arteriosclerosis
The Right Calcium Supplement for all
TELL – H Tabs
Telmisartan 40 mg.+ Hydrochlorothiazide 12.5 mg
- Additive BP reduction and benefits beyond BP lowering1>
- SBP by 30 mmHg1
- New onset of diabetes by 16%1
- HOMA-IR by 15%2
- First choice in hypertension with carotid artery atherosclerosis3
- Decreases IMT by 7%
- Decreases IMT by 7%
- Reverses arteriosclerosis
The Right Calcium Supplement for all
TELL – AM Tabs
Telmisartan 40 mg. + Amlodipine - 5mg
- Additive BP reduction and benefits beyond BP lowering1>
- SBP by 30 mmHg1
- New onset of diabetes by 16%1
- HOMA-IR by 15%2
- First choice in hypertension with carotid artery atherosclerosis3
- Decreases IMT by 7%
- Decreases IMT by 7%
- Reverses arteriosclerosis
The Right Calcium Supplement for all